banner

CAS 1985605-59-1 Baloxavir Powder

Delivery term:The date of payment from buyers deliver within days
  • Price:

    Negotiable

  • minimum:

  • Total supply:

  • Delivery term:

    The date of payment from buyers deliver within days

  • seat:

    Beijing

  • Validity to:

    Long-term effective

  • Last update:

    2020-08-19 08:54

  • Browse the number:

    280

Send an inquiries
Company Profile
Xi'an Yutbon Pharmaceutical Technology Co., Ltd
By certification [File Integrity]
Contact:

yutebang(Mr.)  

Email:

Telephone:

Phone:

Area:

Beijing

Address:

Room 10502, Unit 1, Building1, Accelerator Zone 2, Caotang Science and Technology Industry Base, High-tech Zone, Xi'an,Shaanxi

Website: http://www.yutbonpharma.com/ http://yutebang.fuhuawire.com/
Product details


Baloxavir powder CAS 1985605-59-1, a third-generation antiviral chemical, is the first novel anti-influenza drug approved by THE US FDA in the past 20 years.


Product Name: CAS 1985605-59-1 Baloxavir powder

Synonyms: Baloxavir;CPD2051;Baloxavir Impurity 10;S-033447

CAS: 1985605-59-1

Assay: 99%

MF: C24-H19-F2-N3-O4-S

MW: 483.4931

Standard: Pharmacopoeia

Appearance: White or off-white crystalline powder

Package: In aluminium foil bag or 25kg/ drum


Product Application :

CAS 1985605-59-1 Baloxavir powder has a novel anti-influenza mechanism aimed at combating both influenza A and Influenza B viruses, including tamiflu (Oseltamivir) resistant strains and avian influenza strains (H7N9, H5N1).


Contact information: 


http://www.yutbonpharma.com/